Cowen Downgrades Raptor Pharmaceuticals (RPTP) to Market Perform

September 16, 2016 7:17 AM EDT
Get Alerts RPTP Hot Sheet
Price: $9.00 --0%

Rating Summary:
    7 Buy, 6 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade RPTP Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Cowen downgraded Raptor Pharmaceuticals (NASDAQ: RPTP) from Outperform to Market Perform with a price target of $9.00.

For an analyst ratings summary and ratings history on Raptor Pharmaceuticals click here. For more ratings news on Raptor Pharmaceuticals click here.

Shares of Raptor Pharmaceuticals closed at $8.98 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Cowen & Co

Add Your Comment